FANAX | IENSX | FANAX / IENSX | |
Total Expense Ratio | 0.98 | 0.85 | 115% |
Annual Report Gross Expense Ratio | 0.98 | 0.85 | 115% |
Fund Existence | 29 years | 8 years | - |
Gain YTD | 7.449 | 8.759 | 85% |
Front Load | 6% | N/A | - |
Min. Initial Investment | 0 | 1000000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 952M | 425M | 224% |
Annual Yield % from dividends | 0.88 | 3.64 | 24% |
Returns for 1 year | 7.00 | 10.41 | 67% |
Returns for 3 years | 24.31 | 27.27 | 89% |
Returns for 5 years | 221.77 | 218.13 | 102% |
Returns for 10 years | 76.92 | N/A | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
IBRN | 25.90 | 0.47 | +1.86% |
iShares Neuroscience and Healthcare ETF | |||
BINV | 37.61 | 0.39 | +1.05% |
Brandes International ETF | |||
RSF | 14.80 | 0.02 | +0.14% |
RiverNorth Capital and Income Fund | |||
PTNQ | 74.26 | -0.01 | -0.02% |
Pacer Trendpilot™ 100 ETF | |||
JANM | 32.22 | -0.01 | -0.04% |
FT Vest U.S. Eq Max Buffr ETF - Jan |